270 related articles for article (PubMed ID: 21360803)
1. Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide.
Zhang L; Lu Z; Zhao Q; Huang J; Shen H; Zhang Z
Small; 2011 Feb; 7(4):460-4. PubMed ID: 21360803
[No Abstract] [Full Text] [Related]
2. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
Huang HY; Kuo WT; Chou MJ; Huang YY
J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
[TBL] [Abstract][Full Text] [Related]
4. Self-assembling polyethylenimine derivatives mediate efficient siRNA delivery in mammalian cells.
Creusat G; Zuber G
Chembiochem; 2008 Nov; 9(17):2787-9. PubMed ID: 18972467
[No Abstract] [Full Text] [Related]
5. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
[TBL] [Abstract][Full Text] [Related]
6. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
7. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs.
Zhang L; Xia J; Zhao Q; Liu L; Zhang Z
Small; 2010 Feb; 6(4):537-44. PubMed ID: 20033930
[TBL] [Abstract][Full Text] [Related]
8. Covalent modification of reduced graphene oxide by means of diazonium chemistry and use as a drug-delivery system.
Wei G; Yan M; Dong R; Wang D; Zhou X; Chen J; Hao J
Chemistry; 2012 Nov; 18(46):14708-16. PubMed ID: 23018420
[TBL] [Abstract][Full Text] [Related]
9. Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model.
Liu CW; Xiong F; Jia HZ; Wang XL; Cheng H; Sun YH; Zhang XZ; Zhuo RX; Feng J
Biomacromolecules; 2013 Feb; 14(2):358-66. PubMed ID: 23286342
[TBL] [Abstract][Full Text] [Related]
10. Graphene oxide protected nucleic acid probes for bioanalysis and biomedicine.
Cui L; Song Y; Ke G; Guan Z; Zhang H; Lin Y; Huang Y; Zhu Z; Yang CJ
Chemistry; 2013 Aug; 19(32):10442-51. PubMed ID: 23839798
[TBL] [Abstract][Full Text] [Related]
11. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles.
Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC
Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674
[TBL] [Abstract][Full Text] [Related]
12. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
[TBL] [Abstract][Full Text] [Related]
13. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
[TBL] [Abstract][Full Text] [Related]
14. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
[TBL] [Abstract][Full Text] [Related]
15. Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis.
Duan J; Dong J; Zhang T; Su Z; Ding J; Zhang Y; Mao X
Nanomedicine (Lond); 2014 May; 9(6):789-801. PubMed ID: 24392891
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine-modified PEI: a novel and highly efficient vector for siRNA delivery in mammalian cells.
Creusat G; Zuber G
Nucleic Acids Symp Ser (Oxf); 2008; (52):91-2. PubMed ID: 18776268
[TBL] [Abstract][Full Text] [Related]
17. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
Park K; Lee MY; Kim KS; Hahn SK
Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
Zhou T; Zhou X; Xing D
Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
[TBL] [Abstract][Full Text] [Related]
19. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
20. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.
Shim G; Kim JY; Han J; Chung SW; Lee S; Byun Y; Oh YK
J Control Release; 2014 Sep; 189():80-9. PubMed ID: 24973719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
